Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm

被引:17
|
作者
Zheng, Lei [1 ]
Zhang, Chi-Hao [1 ]
Lin, Jia-Yun [1 ]
Song, Chen-Lu [2 ]
Qi, Xiao-Liang [1 ]
Luo, Meng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Gen Surg, Sch Med, Shanghai Peoples Hosp 9, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Burns & Plast Surg, Sch Med, Shanghai Peoples Hosp 9, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; radiofrequency ablation; surgical resection; overall survival; disease-free survival; LONG-TERM EFFECTIVENESS; HEPATIC RESECTION; TRIAL; METAANALYSIS; HEPATECTOMY;
D O I
10.3389/fonc.2020.00399
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study aims to compare survival outcome after receiving radiofrequency ablation (RFA) and surgical resection (SR) for solitary hepatocellular carcinoma (HCC) with size large as 5 cm. Methods: The SEER database was queried for patients with HCC tumors who were treated with RFA or SR between 2004 and 2015. Univariate and multivariate Cox analysis was used to assess the influence of potential variables on the patients' outcome. Additionally, propensity score matching (PSM) and multiple imputations (MI) were used as sensitivity analyses. Results: Of 1,985 cases, 934 patients received RFA treatment, while the rest underwent surgical resection. The patients in the RFA group had poorer overall survival (OS) and cancer-specific survival (CSS) than those in the SR group regardless of the tumor size before matching and MI. By using PSM analysis at a 1:1 ratio, 1,302 cases were paired and we have found that SR had a positive impact on OS and CSS of patients with tumors measuring from 3.1 to 5 cm. However, when the tumor size was <3 cm, patients undergoing SR had similar survival benefit with those after RFA. The above results were confirmed after performing PSM analysis at a 1:2 and 1:3 ratio. Conclusion: By applying several effective sensitivity analyses, we demonstrated that OS and CSS were similar between the patients with tumors smaller than 3 cm receiving RFA and SR. But SR may be a superior treatment option with better long-term outcome than RFA in patients with tumor measuring 3.1-5 cm.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection
    Yuemin Feng
    Hao Wu
    Daniel Q. Huang
    Chenghui Xu
    Hang Zheng
    Mayumi Maeda
    Xinya Zhao
    Le Wang
    Feng Xiao
    Huanran Lv
    Tiantian Liu
    Jianni Qi
    Jie Li
    Ning Zhong
    Chuanxi Wang
    Hong Feng
    Bo Liang
    Wanhua Ren
    Chengyong Qin
    Mindie H. Nguyen
    Qiang Zhu
    [J]. European Radiology, 2020, 30 : 6357 - 6368
  • [42] Comparative effectiveness of combination TACE/ablation vs. monotherapy in hepatocellular carcinoma.
    Winer, Arthur
    Rosen, Yohei
    Lu, Frederick
    Berman, Russell S.
    Melis, Marcovalerio
    Miller, George
    Pachter, H. Leon
    Newman, Elliot
    Hatzaras, Ioannis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [43] No-Touch Multibipolar Radiofrequency Ablation: The New Standard Ablative Technique for Hepatocellular Carcinoma 5 cm or Smaller?
    Hocquelet, Arnaud
    Papadopoulos, Panteleimon
    Trillaud, Herve
    [J]. RADIOLOGY, 2016, 281 (03) : 975 - 976
  • [44] Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter
    Poon, RTP
    Ng, KKC
    Lam, CM
    Ai, V
    Yuen, J
    Fan, ST
    [J]. ARCHIVES OF SURGERY, 2004, 139 (03) : 281 - 287
  • [45] Cost Effectiveness of Radiofrequency Ablation Versus Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma Less Than 4.5 CM in Diameter
    Rahimi, Robert
    Hair, Clark
    Stukenborg, George
    Al-Osaimi, Abdullah M.
    Argo, Curtis K.
    Northup, Patrick G.
    Caldwell, Stephen H.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A859 - A859
  • [46] Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma
    Zhou, Cheng
    Peng, Yuanfei
    Zhou, Kaiqian
    Zhang, Lan
    Zhang, Xiangyu
    Yu, Lei
    Hu, Jie
    Chen, Feiyu
    Qin, Shuangjian
    Zhou, Jian
    Fan, Jia
    Ren, Zhenggang
    Wang, Zheng
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (01) : 19 - 28
  • [47] Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis
    Guglielmi, Alfredo
    Ruzzenente, Andrea
    Valdegamberi, Alessandro
    Pachera, Silvia
    Campagnaro, Tommaso
    D'Onofrio, Mirko
    Martone, Enrico
    Nicoli, Paola
    Iacono, Calogero
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (01) : 192 - 198
  • [48] Surgical resection versus radiofrequency ablation for early recurrent hepatocellular carcinoma
    Shi, Tongtong
    Xu, Chenghui
    Feng, Yuemin
    Wei, Yingnan
    Lv, Huanran
    Zhu, Qiang
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (08) : 844 - 851
  • [49] Radiofrequency Ablation Versus Surgical Resection for the Treatment of Hepatocellular Carcinoma in Cirrhosis
    Alfredo Guglielmi
    Andrea Ruzzenente
    Alessandro Valdegamberi
    Silvia Pachera
    Tommaso Campagnaro
    Mirko D’Onofrio
    Enrico Martone
    Paola Nicoli
    Calogero Iacono
    [J]. Journal of Gastrointestinal Surgery, 2008, 12 : 192 - 198
  • [50] Radiofrequency ablation of hepatocellular carcinoma sized> 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified?
    Shan Ke
    Xue-Mei Ding
    Xiao-Jun Qian
    Yi-Ming Zhou
    Bao-Xin Cao
    Kun Gao
    Wen-Bing Sun
    [J]. World Journal of Gastroenterology, 2013, 19 (42) : 7389 - 7398